Orbit Biomedical partners with companies developing genetic and cell therapies for delivery to the subretinal space. In addition to the potential for an improved procedure-related safety profile, our investigational technology has the potential to help ensure consistent and accurate placing of the therapeutic in the subretinal space, minimizing losses and variability.
We aim to work collaboratively with each partner as an integral part of their team, to ensure that our device technology and education expertise are integrated seamlessly into program development and commercialization. Our collaborative work is aimed at ensuring that the clinical profile of each partner’s program benefits fully from Orbit Biomedical’s platform.
For more information on partnering with us, reach out to us at